The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Schreiber Alain since year 2005.
The trader's CIK number is 1225149.
At the time of this reporting, Schreiber Alain is the 10% Owner of Avanir Pharmaceuticals .
(stock ticker symbol AVN).
See this page for all insider trading activities at Avanir Pharmaceuticals .
Note that in the past SCHREIBER ALAIN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Schreiber Alain since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-09-15
AVNR
Avanir Pharmaceuticals
Purchase
244,449
.85
207,781
2008-09-16
AVNR
Avanir Pharmaceuticals
Purchase
17,387
.76
13,214
2008-09-17
AVNR
Avanir Pharmaceuticals
Purchase
413,217
.80
330,573
2008-09-08
AVNR
Avanir Pharmaceuticals
Purchase
125,000
.95
118,750
2008-09-09
AVNR
Avanir Pharmaceuticals
Purchase
146,400
.92
134,688
2008-09-10
AVNR
Avanir Pharmaceuticals
Purchase
48,103
.91
43,773
2008-09-04
AVNR
Avanir Pharmaceuticals
Purchase
52,113
.95
49,507
2008-09-03
AVNR
Avanir Pharmaceuticals
Purchase
6,864
.93
6,383
2008-09-02
AVNR
Avanir Pharmaceuticals
Purchase
323,550
.93
300,901
2008-08-27
AVNR
Avanir Pharmaceuticals
Purchase
89,447
.95
84,974
2008-08-14
AVNR
Avanir Pharmaceuticals
Purchase
6,051
.90
5,445
2008-08-15
AVNR
Avanir Pharmaceuticals
Purchase
114,032
.95
108,330
2008-08-06
AVNR
Avanir Pharmaceuticals
Purchase
400
.90
360
2008-08-07
AVNR
Avanir Pharmaceuticals
Purchase
91,380
.98
89,552
2008-08-06
AVNR
Avanir Pharmaceuticals
Purchase
400
.90
360
2008-08-07
AVNR
Avanir Pharmaceuticals
Purchase
91,380
.98
89,552
2008-07-18
OPTR
Optimer Pharmaceuticals Inc
Purchase
943,396
8.48
7,999,998
2007-09-19
CADX
Cadence Pharmaceuticals Inc
Sale
28,800
14.33
412,704
2007-09-18
CADX
Cadence Pharmaceuticals Inc
Sale
7,900
13.50
106,650
2007-09-17
CADX
Cadence Pharmaceuticals Inc
Sale
200
13.50
2,700
2007-09-19
CADX
Cadence Pharmaceuticals Inc
Sale
74,300
13.99
1,039,704
2007-09-12
CADX
Cadence Pharmaceuticals Inc
Sale
2,500
13.63
34,083
2007-09-14
CADX
Cadence Pharmaceuticals Inc
Sale
500
13.50
6,750
2007-01-05
NVD
Novadel Pharma Inc
Purchase
961,914
1.45
1,394,775
2006-04-12
NVD
Novadel Pharma Inc
Purchase
689,656
1.45
1,000,001
2005-11-29
PTN
Palatin Technologies Inc
Sale
358,000
3.92
1,405,150
2005-10-28
THLD
Threshold Pharmaceuticals Inc
Sale
110,364
10.46
1,154,407
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Schreiber Alain
(10% Owner of Avanir Pharmaceuticals at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
